Kea Martin

1.0k total citations
15 papers, 763 citations indexed

About

Kea Martin is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Kea Martin has authored 15 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Kea Martin's work include Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (5 papers). Kea Martin is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (5 papers). Kea Martin collaborates with scholars based in Switzerland, Germany and United States. Kea Martin's co-authors include Alfred Zippelius, Philipp Müller, Michael von Bergwelt‐Baildon, Jens Schreiner, Daniela S. Thommen, Hans Kreipe, Viola Heinzelmann‐Schwarz, Ulrike Nitz, Didier Lardinois and Matthias Kreuzaler and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Gut.

In The Last Decade

Kea Martin

14 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kea Martin Switzerland	11	486	283	197	136	100	15	763
Enrico Saggiorato Italy	19	258 0.5×	354 1.3×	69 0.4×	294 2.2×	47 0.5×	22	1.2k
Matthew McCourt United Kingdom	9	189 0.4×	141 0.5×	47 0.2×	171 1.3×	56 0.6×	18	543
Brett H. Herzog United States	12	631 1.3×	383 1.4×	21 0.1×	333 2.4×	116 1.2×	17	1.1k
Gilad W. Vainer Israel	14	257 0.5×	78 0.3×	34 0.2×	297 2.2×	213 2.1×	28	700
Anna-Maria Larsson Sweden	14	480 1.0×	226 0.8×	33 0.2×	232 1.7×	135 1.4×	27	859
Marielle Chiron France	12	440 0.9×	125 0.4×	109 0.6×	299 2.2×	72 0.7×	44	745
Antonios Papanicolau‐Sengos United States	12	275 0.6×	158 0.6×	21 0.1×	237 1.7×	149 1.5×	36	563
Wende Kozlow United States	7	327 0.7×	65 0.2×	73 0.4×	196 1.4×	64 0.6×	9	494
Chiara Lambertini Switzerland	15	607 1.2×	118 0.4×	202 1.0×	250 1.8×	174 1.7×	26	862
Mihalis S. Kariolis United States	8	326 0.7×	398 1.4×	70 0.4×	241 1.8×	100 1.0×	10	692

Countries citing papers authored by Kea Martin

Since Specialization

Citations

This map shows the geographic impact of Kea Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kea Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kea Martin more than expected).

Fields of papers citing papers by Kea Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kea Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kea Martin. The network helps show where Kea Martin may publish in the future.

Co-authorship network of co-authors of Kea Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Kea Martin. A scholar is included among the top collaborators of Kea Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kea Martin. Kea Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Martin, Kea, Jean‐Philippe Carralot, Petra Herzig, et al.. (2024). Abstract 4071: The first-in-class PD1-IL18 conjugate BPT567 induces potent anti-tumor immunity by preferentially activating PD1+IL18R+ intratumoral effector T cells in cis. Cancer Research. 84(6_Supplement). 4071–4071. 1 indexed citations

Carralot, Jean‐Philippe, Kea Martin, Roy A. Meoded, et al.. (2023). Abstract 1850: A first-in-class PD1-IL18 immunocytokine (BPT567) targets PD-1+ IL18R+ CD8+ T effector cells enriched in the tumor microenvironment and exhibits potent antitumor efficacy with excellent tolerability. Cancer Research. 83(7_Supplement). 1850–1850. 3 indexed citations

Israël, Laura, Anton Glück, Kea Martin, et al.. (2021). CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo. Oncogenesis. 10(4). 32–32. 10 indexed citations

Hänggi, Pascal, et al.. (2021). Decrease in Serum Anti-MAG Autoantibodies Is Associated With Therapy Response in Patients With Anti-MAG Neuropathy. Neurology Neuroimmunology & Neuroinflammation. 9(1). 23 indexed citations

Beibel, Martin, Kea Martin, Rachel Cuttat, et al.. (2020). Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis. JCI Insight. 5(3). 111 indexed citations

Kashyap, Abhishek S., Yun Zhao, Gianni Monaco, et al.. (2019). GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses. Cell Reports. 28(13). 3367–3380.e8. 50 indexed citations

Martin, Kea, Kiichi Murakami, Laura Israël, et al.. (2019). Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell–Mediated Autoimmunity. The Journal of Immunology. 203(11). 2791–2806. 14 indexed citations

Müller, Philipp, Matthias Kreuzaler, Tarik A. Khan, et al.. (2015). Trastuzumab emtansine (T-DM1) renders HER2 ⁺ breast cancer highly susceptible to CTLA-4/PD-1 blockade. Science Translational Medicine. 7(315). 315ra188–315ra188. 269 indexed citations

Martin, Kea, Jens Schreiner, & Alfred Zippelius. (2015). Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs. Frontiers in Immunology. 6. 501–501. 36 indexed citations

10.

Müller, Philipp, Kea Martin, Sebastian Theurich, et al.. (2014). Microtubule-Depolymerizing Agents Used in Antibody–Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells. Cancer Immunology Research. 2(8). 741–755. 150 indexed citations

11.

Müller, Philipp, Kea Martin, Sebastian Theurich, Michael von Bergwelt‐Baildon, & Alfred Zippelius. (2014). Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity. OncoImmunology. 3(8). e954460–e954460. 23 indexed citations

12.

Martin, Kea, Philipp Müller, Jens Schreiner, et al.. (2014). The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity. Cancer Immunology Immunotherapy. 63(9). 925–938. 60 indexed citations

13.

Martin, Kea, Philipp Mueller, Jens Schreiner, et al.. (2014). Microtubule-Depolymerizing Agents Used in Antibody-Drug-Conjugates Induce Antitumor Activity by Stimulation of Dendritic Cells. Annals of Oncology. 25. vi3–vi3. 1 indexed citations

14.

Martin, Kea, Philipp Mueller, Sebastian Theurich, et al.. (2014). P60. Microtubule-depolymerising agents used in antibody-drug-conjugates induce anti-tumour immunity by stimulation of dendritic cells. Journal for ImmunoTherapy of Cancer. 2(S2).

15.

Martin, Kea, et al.. (1993). Immunology and pathophysiology. Gut. 34(3 Suppl). S37–S38. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact